Tap Global Group (AQSE: TAP), the regulated crypto app, announced the admission of its shares to trading on the Access Segment of the AQSE Growth Market, having raised gross proceeds
Tap Global Group (AQSE: TAP), the regulated crypto app, announced the admission of its shares to trading on the Access Segment of the AQSE Growth Market, having raised gross proceeds
Nanoco Group (NANO), a specialist in the development and manufacture of cadmium-free quantum dots, announced that a term sheet for a no fault settlement of the current litigation has been
It would appear that it is take two as far as Hydrogen Utopia International (HUI)’s move to the standard list of the LSE. The company specialising in turning waste plastic
Leeds, UK – December 30, 2022 – 4D pharma plc (AIM: DDDD) (in administration), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived
Synergia Energy (SYN) announced it has submitted a formal application for its removal from the Official List of the Australian Securities Exchange pursuant to ASX Listing Rule 17.11. This would
4D pharma’s Blautix® Phase II Clinical Trial Results Published in Alimentary Pharmacology & Therapeutics
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Dax, Dow, Bitcoin, BSF,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Dax, Dow, Bitcoin, Aston,
Three RAF airfields hosted Typhoon and Lightning fighter planes. One pilot described the experience as “fantastic”.
4D pharma Announces Two Presentations at The Society for Immunotherapy of Cancer Annual Meeting (SITC 2022)
Leeds, UK, September 28, 2022 , – 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from